Showing 781-790 of 2876 results for "".
- YoungMD Connect Review: Tell-All Tribunehttps://modernaesthetics.com/news/youngmd-connect-review-tell-all-tribune/2473573/The Tell-All Tribune aesthetic think tank in Fort Lauderdale, Florida, in April emerged as a groundbreaking collaborative conference, providing a platform where thought leaders in aesthetics converged to shape the future of the field. Under the leadership of course director Shino Bay Aguilera, DO
- Aesthetic Society Names New Presidenthttps://modernaesthetics.com/news/aesthetic-society-names-new-president/2473569/The Aesthetic Society announced the appointment of Kiya Movassaghi, MD, DMD, FACS, a board-certified plastic surgeon from Eugene, Oregon, as its president, saying his leadership will focus on strategically fortifying The Society's position as the global leader in education and innov
- New Breast Implant Is MDR-Approvedhttps://modernaesthetics.com/news/new-breast-implant-is-mdr-approved/2473566/The new European Medical Device Regulation (MDR) has approved a breast implant for the first time, according to a press release from GC Aesthetics® (GCA®). Under the new MDR rules set forth by the European Union (EU), medical standards are updated rigorousl
- Tell-All Tribune Explores Most Important Topics in Aesthetic Medicinehttps://modernaesthetics.com/news/tell-all-tribune-explores-most-important-topics-in-aesthetic-medicine/2473565/The inaugural Tell-All Tribune: An Aesthetic Think Tank was held in Fort Lauderdale, Florida, from April 18-20, and could perhaps be summed up in six words from course director Shino Bay Aguilera, DO: “What we do goes beyond vanity." Along with fellow course directors Michell
- FDA Issues Alert for Counterfeit Botox Across Multiple U.S. Stateshttps://modernaesthetics.com/news/fda-issues-alert-for-counterfeit-botox-across-multiple-us-states/2473560/The U.S. Food and Drug Administration (FDA) has issued an alert regarding counterfeit botulinum toxin that has been detected in several states. The agency issued a statement on April 16 noting that it is aware of the issue and is working with the Centers for Disease Control (CDC),
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- Highlights From IMCAS World Congress 2024: 25 years at the Forefront of Medical Aesthetics and Countinghttps://modernaesthetics.com/news/highlights-from-imcas-world-congress-2024-25-years-at-the-forefront-of-medical-aesthetics-and-counting-1/2473561/As a veteran of the International Master Course on Aging Science (IMCAS) for over two decades, IMCAS 2024 was the largest congress to date with over 18,000 attendees in the Palais des Congres. Located in central Paris, we had to navigate a construction zone as workmen were busy getting the city r
- Nordic Pharma Welcomes John P. Fezza, MD, to Medical Advisory Boardhttps://modernaesthetics.com/news/nordic-pharma-welcomes-john-fezza-md-to-medical-advisory-board/2473554/Nordic Pharma, Inc., has announced the appointment of renowned oculoplastic surgeon Dr. John P. Fezza, MD, to its U.S. Medical Advisory Board (MAB), according to a press release. The appointment comes as Nordic Pharma prepares to introduce LACRIFILL® Canalicular Gel, a groundb
- FDA Approves Juvederm Voluma XC for Temple Hollowinghttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-temple-hollowing/2473553/Allergan Aesthetics has received FDA approval of Juvederm Voluma XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.[1] The injection is the first and only hyaluronic acid (HA) dermal filler to receive FDA approval